Log In
Print
BCIQ
Print
Print this Print this
 

1070806

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHumanized mAb against interleukin-18 (IL-18)
Molecular Target Interleukin-18 (IL-18)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today